| |
 |
|
Class Information
Number: 424/190.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from bacterium (e.g., mycoplasma, anaplasma, etc.)
Description: Subject matter wherein the disclosed amino acid sequence is derived from a bacterial protein or fragment thereof.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6013514 |
Haemophilus outer membrane protein |
Jan. 11, 2000 |
| 6004556 |
Staphylococcus aureus RSBU-1 |
Dec. 21, 1999 |
| 6001372 |
Antigenic peptides of Chlamydia trachomatis |
Dec. 14, 1999 |
| 6001362 |
Compounds |
Dec. 14, 1999 |
| 6001361 |
Mycobacterium vaccae antigens |
Dec. 14, 1999 |
| 5989884 |
HisS polypeptides from Chlamydia trachomatis |
Nov. 23, 1999 |
| 5989553 |
Expression library immunization |
Nov. 23, 1999 |
| 5989547 |
Leptospiral outer membrane proteins |
Nov. 23, 1999 |
| 5985288 |
Outer membrane protein P1 and peptides of Haemophilus influenzae type B |
Nov. 16, 1999 |
| 5980909 |
Epitopic regions of pneumococcal surface protein A |
Nov. 9, 1999 |
| 5976544 |
Polypeptides and vaccines for Bordetellapertussis and method of use |
Nov. 2, 1999 |
| 5976543 |
12-kDa protein derived from M. Tuberculosis useful for treatment of autoimmune diseases |
Nov. 2, 1999 |
| 5976542 |
Compositions and methods for treatment of streptococcus pneumoniae infection |
Nov. 2, 1999 |
| 5962636 |
Peptides capable of modulating inflammatory heart disease |
Oct. 5, 1999 |
| 5961979 |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
Oct. 5, 1999 |
| 5958416 |
Heat shock protein peptides and methods for modulating autoimmune central nervous system disease |
Sep. 28, 1999 |
| 5955077 |
Tuberculosis vaccine |
Sep. 21, 1999 |
| 5955090 |
Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa membrane proteins |
Sep. 21, 1999 |
| 5955596 |
NucA protein of Haemophilus influenzae and the gene encoding that protein |
Sep. 21, 1999 |
| 5955078 |
Fibronectin binding protein polypeptides |
Sep. 21, 1999 |
| 5951980 |
Identification, production and use of new staphylokinase derivatives with reduced immunogenicity |
Sep. 14, 1999 |
| 5935580 |
Recombinant mutants for inducing specific immune responses |
Aug. 10, 1999 |
| 5932483 |
Synthetic peptide and its uses |
Aug. 3, 1999 |
| 5932220 |
Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov. |
Aug. 3, 1999 |
| 5932217 |
Peptides which inhibit adhesion between leukocytes and endothelial cells |
Aug. 3, 1999 |
| 5932705 |
Methods and compositions for the treatment and diagnosis of shipping fever |
Aug. 3, 1999 |
| 5928644 |
T-cell epitopes |
Jul. 27, 1999 |
| 5928900 |
Bacterial exported proteins and acellular vaccines based thereon |
Jul. 27, 1999 |
| 5925546 |
Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
Jul. 20, 1999 |
| 5922323 |
Transferrin receptor genes and immunogenic compositions derived therefrom |
Jul. 13, 1999 |
| 5916572 |
Compounds and methods for the detection and prevention of T. cruzi infection |
Jun. 29, 1999 |
| 5916562 |
Membrane proteins and peptides of haemophilus influenzae type B |
Jun. 29, 1999 |
| 5911996 |
43 Kd protein vaccine and method for the production thereof |
Jun. 15, 1999 |
| 5889172 |
DNA sequences for immunologically active peptides of pertussis toxin |
Mar. 30, 1999 |
| 5876725 |
Actinobacillus pleuropneumoniae transferrin binding protein vaccines and uses thereof |
Mar. 2, 1999 |
| 5871742 |
Recombinant Avipox virus encoding polypeptide of mycoplasma gallisepticum, and utilized a live vaccine |
Feb. 16, 1999 |
| 5869065 |
High molecular weight surface proteins of non-typeable haemophilus |
Feb. 9, 1999 |
| 5869058 |
Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
Feb. 9, 1999 |
| 5869064 |
Protein rib, a cell surface protein that confers immunity to many strains of the group B Streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
Feb. 9, 1999 |
| 5866130 |
Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
Feb. 2, 1999 |
| 5863543 |
Camp factor of streptococcus uberis |
Jan. 26, 1999 |
| 5861157 |
Diagnosis and treatment of infections due to Streptococci and Enterococci |
Jan. 19, 1999 |
| 5859207 |
Superantigen agonist and antagonist peptides |
Jan. 12, 1999 |
| 5858367 |
Methods for screening for antimicrobials utilizing AarC and compositions thereof |
Jan. 12, 1999 |
| 5858965 |
Pharmaceutical compositions for the treatment of autoimmune diseases comprising the B-oligomer of pertussis toxin or its subunits |
Jan. 12, 1999 |
| 5849295 |
Nucleotide sequences coding for a protein with urease activity |
Dec. 15, 1998 |
| 5840855 |
Mycobacterial recombinants and peptides |
Nov. 24, 1998 |
| 5837825 |
Campylobacter jejuni flagellin/Escherichia coli LT-B fusion protein |
Nov. 17, 1998 |
| 5837263 |
Leptospira membrane proteins |
Nov. 17, 1998 |
| 5830710 |
Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
Nov. 3, 1998 |
|
|
|
